0 antall prosjekter

PES-EU-Prosjektetablererstøtte EU (bedrift)

A Late-Stage Clinical Development Programme of SER101 (an Oral 5-HT4 Receptor Antagonist) as a New Chemical Entity in the Treatment of Conge

...

Tildelt: kr 0,21 mill.

Prosjektperiode: 2010-2011

Sted: Oslo